Beyond Air (XAIR) Cash & Equivalents Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 | 9.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.06% |
| Sep 30, 2025 | -65.91% |
| Jun 30, 2025 | -49.64% |
| Mar 31, 2025 | -86.56% |
| Dec 31, 2024 | -42.28% |
| Sep 30, 2024 | 115.85% |
| Jun 30, 2024 | -58.03% |
| Mar 31, 2024 | -35.13% |
| Dec 31, 2023 | -87.39% |
| Sep 30, 2023 | -55.82% |
| Jun 30, 2023 | -56.92% |
| Mar 31, 2023 | -33.34% |
| Dec 31, 2022 | -24.28% |
| Sep 30, 2022 | -37.46% |
| Jun 30, 2022 | 88.62% |
| Mar 31, 2022 | 131.71% |
| Dec 31, 2021 | 279.12% |
| Sep 30, 2021 | 119.64% |
| Jun 30, 2021 | 62.05% |
| Mar 31, 2021 | 74.65% |
| Dec 31, 2020 | 928.71% |
| Sep 30, 2020 | 1,045.78% |
| Jun 30, 2020 | 3,642.40% |
| Mar 31, 2020 | 1,379.57% |
| Dec 31, 2019 | 346.15% |
| Sep 30, 2019 | 499.81% |
| Jun 30, 2019 | 64.82% |
| Mar 31, 2019 | 82.95% |
| Dec 31, 2018 | -60.08% |
| Sep 30, 2018 | -81.96% |
| Jun 30, 2018 | -92.56% |
| Mar 31, 2018 | -89.74% |
| Dec 31, 2017 | 17,066.49% |
| Sep 30, 2017 | 8,660.00% |
| Jun 30, 2017 | 259,350.00% |
| Mar 31, 2017 | 23,703.33% |
| Dec 31, 2016 | -94.57% |